Huang, Chun-Ta
Lin, Chih-An
Su, Te-Jen
Yang, Ching-Yao
Tsai, Tzu-Hsiu
Hsu, Chia-Lin
Liao, Wei-Yu
Chen, Kuan-Yu
Ho, Chao-Chi
Yu, Chong-Jen
Funding for this research was provided by:
AstraZeneca (ISSIRES0105)
Article History
Received: 7 January 2023
Accepted: 2 March 2023
First Online: 13 March 2023
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the research ethics committee of National Taiwan University Hospital (201304074RIPC) and informed consent was taken from all individual participants.
: Not applicable.
: Chao-Chi Ho has received honoraria for speeches or compensation for participation in advisory boards from Boehringer Ingelheim, Eli Lilly, Roche/Genentech/Chugai, MSD, Pfizer, Novartis, Bristol-Myers Squibb, and Ono Pharmaceutical. The other authors have no conflicts of interest to declare.